Sensex Dips 142 Points Nifty Holds Above 23900 as Mid and SmallCaps Shine Stocks Edge Higher as Iran Peace Talks Show Progress Charter Communications Agrees to Acquire Liberty Broadband in Enhanced Offer Meta Settles Social Media Addiction Lawsuit with US School District in Potential Precedent for Numerous Similar Cases European Commissions EV Push Faces Practical Hurdles as Own Fleet Struggles on Strasbourg Route Market Expert Ganesh Dongre Identifies Potential Stock Opportunities Amid Middle East Tensions SNSE Q1 2026 Earnings EPS Significantly Below Estimates as Company Invests in Pipeline Dynex Capital DX Q1 2026 Earnings EPS Misses Estimates Stock Rises Amid Rate Uncertainty ArcBest ARCB Q1 2026 Earnings EPS Surges Past Estimates in Modest Volume Environment ARQ Q1 2026 Earnings Narrower Loss Beats Estimates Shares Edge Higher Compass Therapeutics Q1 2026 Earnings Narrowed Loss and Positive Surprise as Pipeline Progress Continues FPH Q1 2026 Earnings Narrowing Loss Amid Challenging Market Conditions Tootsie Roll Industries TR Holds Steady Near Support as Confectionary Sector Shows Resilience Bank of the James Financial Group Inc BOTJ Edges Lower Amid Light Trading Support Levels in Focus Sizzle Acquisition Corp II Right SZZLR Holds Steady at 016 as Trading Range Tightens Ionis Pharmaceuticals Holds Steady Near Support as Biotech Sector Eyes Catalysts KORU Medical Systems KRMD Gains 26 as Stock Challenges Resistance Near 442 Eastman Kodak KODK Shares Jump Nearly 4 as Stock Rebounds from Support MainStreet Bancshares Inc MNSB Edges Lower Amid Low Volume Key Levels Hold Energous Corporation WATT Edges Higher Testing Resistance After Support Hold Vistagen Therapeutics VTGN Approaches Key Support After Marginal Decline Apex Treasury Corporation APXT Holds Steady at 1002 Key Support and Resistance Levels in Focus Daedalus Special Acquisition Corp Warrants DSACW Remain Flat at 045 as Market Awaits Catalysts EU and Mexico Sign Updated Trade Deal to Strengthen Economic Ties Amid Geopolitical Shifts IBEX Q1 2026 Earnings EPS Beats Estimates Revenue Not Disclosed Agios Pharmaceuticals AGIO Slips 226 as Stock Tests Key Support at 2673